HealthBeacon CEO Jim Joyce Resigns

Co-founder steps down after three years

Dublin-based medtech company announces leadership change

Dublin, Ireland - HealthBeacon, a leading digital therapeutics company, today announced that its former CEO Jim Joyce has resigned from his role. Joyce co-founded HealthBeacon in 2019 and has led the company through a period of significant growth and innovation.

Under Joyce's leadership, HealthBeacon has developed a suite of digital therapeutics solutions for a range of chronic conditions, including diabetes, obesity, and hypertension. The company's products have been used by over 1 million patients worldwide and have shown promising results in improving patient outcomes.

Joyce's resignation comes as HealthBeacon prepares for its next phase of growth. The company recently closed a $50 million Series B funding round and is expanding its operations into new markets.

HealthBeacon's board of directors has appointed David Hickey, the company's former chief operating officer, as interim CEO. Hickey has been with HealthBeacon since its inception and has played a key role in the company's success.

A search for a permanent CEO is underway.